Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial) - Rationale and study design Tobias Geisler

Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial) - Rationale and study design Tobias Geisler Reviewed by Carmen Lahiff-Jenkins on Monday, February 13, 2017 Rating: 5

No comments:

All Rights Reserved by World Stroke Organization © 2017

Contact Form

Name

Email *

Message *

Powered by Blogger.